鲁抗医药：上半年净利润同比下降64.38%

Core Insights - The company reported a revenue of 3.154 billion yuan for the first half of 2025, representing a year-on-year decrease of 3.83% [1] - The net profit attributable to shareholders of the listed company was 107 million yuan, down 64.38% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 100 million yuan, showing a year-on-year increase of 9.16% [1] - The basic earnings per share were 0.12 yuan [1]